Understanding Your Wegovy vs Mounjaro UK Options
Wegovy vs Mounjaro UK: Key Mechanism Differences for Prescription Weight Loss
When evaluating Wegovy vs Mounjaro UK options for prescription weight loss, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after smaller meals. This targeted approach has been extensively studied in the STEP clinical trial programme, demonstrating consistent weight management outcomes when used alongside a reduced-calorie diet and increased physical activity.
Mounjaro, containing tirzepatide, operates as a dual agonist targeting both GIP and GLP-1 receptors simultaneously. This broader hormonal approach may influence glucose metabolism and appetite regulation through multiple pathways. Both treatments require clinical assessment and ongoing prescriber supervision, as they are prescription-only medicines with specific eligibility criteria including BMI ≥30 or BMI ≥27 with weight-related comorbidities. Understanding these mechanistic differences helps inform the Wegovy vs Mounjaro UK decision alongside professional medical guidance.
Wegovy vs Mounjaro UK Pricing: Comprehensive Cost Comparison
The Wegovy vs Mounjaro UK pricing landscape differs significantly across dose escalation phases. Wegovy follows a structured 20-week titration schedule starting with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose at £209.99. Our Getting Started bundles provide convenience for the escalation journey, with the Intro Duo (0.25mg & 0.5mg) priced at £169.99 and Progress Trio covering three months at £299.99. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Mounjaro pricing follows its own dose escalation from 2.5mg through to 15mg maintenance, though specific UK pricing varies by supplier and dose strength. The Wegovy vs Mounjaro UK cost comparison must consider the full treatment duration, as both require long-term commitment for sustained weight management. EverydayMeds offers comprehensive bundle options including our Ultimate Stability Trio providing three months of 2.4mg maintenance supply for £649.99, ensuring treatment continuity without frequent reordering.
Clinical Evidence: Wegovy vs Mounjaro UK Trial Data
The STEP clinical programme provides robust evidence for Wegovy's efficacy, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks versus 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, highlighting broader health benefits beyond weight management. These results represent outcomes in clinical trial conditions with intensive support, and individual results may vary.
Mounjaro's clinical evidence stems from the SURMOUNT trial programme, though direct head-to-head Wegovy vs Mounjaro UK comparisons are limited due to different trial designs, populations, and endpoints. Both treatments have demonstrated clinically meaningful weight loss when used alongside lifestyle modifications, but the specific patient populations and study protocols differ. Your prescriber can help interpret this evidence in the context of your individual circumstances and health profile.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy's semaglutide works by activating GLP-1 receptors found throughout your digestive system and brain areas controlling appetite. When you eat, natural GLP-1 hormones signal fullness to your brain, but these signals are typically short-lived. Wegovy provides prolonged GLP-1 receptor activation, extending these satiety signals and reducing the urge to eat between meals. The medication may also slow gastric emptying, helping you feel satisfied with smaller portions for longer periods. This isn't appetite suppression in the traditional sense, but rather supporting your body's natural fullness mechanisms that may have become less effective over time.
Streamlined Ordering Process: Getting Started with Wegovy
Beginning your Wegovy vs Mounjaro UK evaluation starts with our comprehensive 3-minute clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (24-hour express service available), ensuring thorough evaluation of your suitability for treatment. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy (#9012878) and shipped via next-day cold-chain delivery to maintain optimal storage conditions. The FlexTouch pen system requires no mixing or preparation, with clear dose escalation instructions provided. Regular follow-up assessments ensure ongoing treatment safety and effectiveness monitoring throughout your weight management journey.
Storage and Practical Considerations: Wegovy vs Mounjaro UK
A significant practical advantage in the Wegovy vs Mounjaro UK comparison is storage flexibility during travel and daily use. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more suitable for business travel, holidays, or situations where consistent refrigeration isn't assured. Both treatments require refrigerated storage (2-8°C) before first use, but Wegovy's superior temperature tolerance reduces storage-related treatment interruptions. The once-weekly injection schedule for both treatments supports adherence compared to daily medications, with injections typically administered on the same day each week at any time.
Making Your Wegovy vs Mounjaro UK Decision: Professional Guidance
The optimal choice in your Wegovy vs Mounjaro UK comparison depends on multiple individual factors including your medical history, concurrent medications, lifestyle requirements, and treatment preferences. Some patients may respond better to GLP-1-only receptor activation, whilst others might benefit from dual receptor targeting. Previous experience with similar medication classes, injection tolerance, and storage requirements all influence treatment selection. Your prescriber will consider these factors alongside current clinical evidence to recommend the most appropriate option.
Both Wegovy and Mounjaro are available from EverydayMeds, allowing flexibility in treatment choice based on professional medical assessment rather than availability constraints. Regular monitoring and dose adjustments ensure optimal outcomes regardless of which treatment is selected, with the option to switch between treatments if clinical circumstances change. The key is starting with professional evaluation to determine your individual suitability for prescription weight loss treatment.
Start Your Prescription Weight Loss Journey Today
Your Wegovy vs Mounjaro UK decision begins with professional clinical assessment through our streamlined online process. New customers can use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our competitive pricing structure. Our experienced clinical team provides ongoing support throughout your treatment journey, from initial assessment through maintenance dosing and beyond. Whether you choose Wegovy's proven GLP-1 approach or explore Mounjaro's dual-receptor mechanism, both treatments are available with next-day delivery and comprehensive patient support. Take the first step towards medically supervised weight management with confidence in our GPhC-registered service and clinical expertise.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
